A shadow market for unapproved weight-loss medications is being driven by social media fitness personalities and sellers on communication apps, based on recent findings.
Experimental Drug Gaining Popularity Online
The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its supposed fat-burning effects. Followers are encouraged to contact these profiles privately for supplier links, while also receiving promotional offers.
Thriving Commerce on Social Networks
Additionally, a flourishing trade exists on messaging services, where communities with numerous of members share “before and after” images, administration instructions and claims of rapid British shipping. Sellers promote the drug there before directing customers to WhatsApp for purchases.
Learning About The Experimental Drug
Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.
Medical Professionals Voice Concerns
Nevertheless, doctors and chemists have warned that the sale of what is still an unapproved drug in the UK is worrisome and could lead to users injecting substances of uncertain source.
Some professionals stated the demand for the experimental drug could be linked to the increasing price of approved slimming products such as Mounjaro.
Regulatory Position and Implementation
Marketing the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.
Several content creators attempt to circumvent the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still violate medicines, marketing, and consumer laws, potentially leading to fines, legal action or imprisonment.
Platform Response and Content Removal
According to TikTok, the platform has taken down problematic material and prohibited related hashtags and search suggestions. The company stated it was committed to keeping the service secure and allocating resources in enhancing enforcement strategies.
Online Trading Activities
Investigations also found groups with up to nine thousand members marketing retatrutide using the platform's built-in search feature, which functions like a public directory. Entering “retatrutide” immediately displays channels with numerous of users, filled with images of slimming results, glowing testimonials and detailed guides for preparing or administering at home.
Within moments of entering one community, a vendor shared WhatsApp details, where most purchases take place. The vendor sent an instruction manual and promised delivery within 48 hours. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one inquired about weight, medical conditions or past usage.
Product Information and Pricing
Inside these groups, messages show black plastic packages with Royal Mail stickers, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, mixed at residence with sterile water, or pre-filled injectors typically priced at £160 for 20mg. When questioned how much time a pen should be used, sellers give contradictory responses varying between a few weeks to “depends on your body”.
Platform Oversight and Safety Actions
A representative for Telegram said it actively monitored dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Cautions
“Individuals are administering substances they cannot confirm. Even if the research behind this drug is sound, these online products may not include what they claim,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.
A medical professional of an online medical service linked the increase in interest to recent price rises for authorized slimming medications such as Mounjaro. “With prices increasing, individuals are using social media. But counterfeit injections are highly dangerous. You cannot know what’s contained or whether the environment they were produced in was sterile,” she explained.
Her staff has previously seen individuals harmed by self-injection from unconfirmed suppliers. “We recognize the disappointment, but purchasing from Telegram or communication platforms is taking chances with your well-being,” said the doctor. “These substances could be impure or incorrectly dosed.”
Manufacturer Statement
A spokesperson from the pharmaceutical company said retatrutide was in third stage research studies and had not been reviewed or approved by any government authority globally. “Consequently at this point no one can market [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a company investigational product not yet approved … may subject patients to possibly serious health risks”.
